1-12 of 12
Ross I. Baker
Close
Sort by
Journal Articles

Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies

Ferdows Atiq, Robin Blok, Calvin B. van Kwawegen, Dearbhla Doherty, Michelle Lavin, Johanna G. van der Bom, Niamh M. O'Connell, Joke de Meris, Kevin Ryan, Saskia E. M. Schols, Mary Byrne, Floor C. J. I. Heubel-Moenen, Karin P. M. van Galen, Roger J. S. Preston, Marjon H. Cnossen, Karin Fijnvandraat, Ross I. Baker, Karina Meijer, Paula James, Jorge Di Paola, Jeroen Eikenboom, Frank W. G. Leebeek, James S. O'Donnell
Journal: Blood
Blood (2024) 143 (14): 1414–1424.
https://doi.org/10.1182/blood.2023022457
Published: 2024
Includes: Supplemental data
Journal Articles

How I treat bleeding disorder of unknown cause

Ross I. Baker, James S. O’Donnell
Journal: Blood
Blood (2021) 138 (19): 1795–1804.
https://doi.org/10.1182/blood.2020010038
Published: 2021
Journal Articles

Clinical Outcomes in Adults/Adolescents with Hemophilia B Treated Long Term with Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis: Interim Results of the B-Yond Extension Study

Tadashi Matsushita, Johnny Mahlangu, Amy D Shapiro, K John Pasi, Margaret V. Ragni, MD, Margareth C Ozelo, Johannes Oldenburg, Prof, Ross I Baker, Huixing Yuan, Alejandra Ramirez-Santiago, Francesca Ferrante, Stefan Lethagen
Journal: Blood
Blood (2016) 128 (22): 1416.
https://doi.org/10.1182/blood.V128.22.1416.1416
Published: 2016
Journal Articles

Andexanet Alfa Corrects the Interference of Direct Factor Xa Inhibitors on Lupus Anticoagulant Testing

Ross I Baker, MD, Grace Gilmore, Scott McGregor, BPharm
Journal: Blood
Blood (2016) 128 (22): 2626.
https://doi.org/10.1182/blood.V128.22.2626.2626
Published: 2016
Journal Articles

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A

Clinical Trials & Observations
Johnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim, Oleksandra Stasyshyn, Marina V. Kosinova, Lynda Mae Lepatan, Aleksander Skotnicki, Lisa N. Boggio, Robert Klamroth, Johannes Oldenburg, Andrzej Hellmann, Elena Santagostino, Ross I. Baker, Kathelijn Fischer, Joan C. Gill, Stephanie P’Ng, Pratima Chowdary, Miguel A. Escobar, Claudia Djambas Khayat, Luminita Rusen, Debra Bensen-Kennedy, Nicole Blackman, Tharin Limsakun, Alex Veldman, Katie St. Ledger, Ingrid Pabinger, for the AFFINITY Investigators
Journal: Blood
Blood (2016) 128 (5): 630–637.
https://doi.org/10.1182/blood-2016-01-687434
Published: 2016
Includes: Supplemental data
Journal Articles

Extended-Interval Prophylaxis with rFIXFc in Adults and Adolescents with Hemophilia B: Interim Results of the B-YOND Extension Study

Johnny Mahlangu, Amy D Shapiro, MD, K John Pasi, Margaret V Ragni, Margareth Castro Ozelo, MD PhD, Johannes Oldenburg, Tadashi Matsushita, MD PhD, Ross I Baker, MD, Huixing Yuan, Alejandra Ramirez-Santiago, Glenn F Pierce, Geoffrey Allen, Baisong Mei
Journal: Blood
Blood (2015) 126 (23): 1088.
https://doi.org/10.1182/blood.V126.23.1088.1088
Published: 2015
Journal Articles

Low Bleeding Rates with Increase or Maintenance of Physical Activity in Patients Treated with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in the A-LONG and Kids A-LONG Studies

Doris V. Quon, Robert Klamroth, Roshni Kulkarni, Amy D Shapiro, MD, Ross I Baker, MD, Giancarlo Castaman, Bryce A. Kerlin, Elisa Tsao, Geoffrey Allen
Journal: Blood
Blood (2015) 126 (23): 3543.
https://doi.org/10.1182/blood.V126.23.3543.3543
Published: 2015
Journal Articles

Analysis of Target Joint Bleeding with Prophylactic Use of Recombinant Factor IX Fc Fusion Protein in Patients with Severe Hemophilia B

Amy D Shapiro, MD, David J Perry, Ross I Baker, MD, Elisa Tsao, Baisong Mei
Journal: Blood
Blood (2015) 126 (23): 2294.
https://doi.org/10.1182/blood.V126.23.2294.2294
Published: 2015
Journal Articles

Rviii-Singlechain in Surgical Prophylaxis: Efficacy and Safety of Continuous and Bolus Infusion

Claudia Djambas Khayat, MD BS, Johnny N. Mahlangu, MD, Ross I Baker, MD, Cindy A. Leissinger, MD, Elena Santagostino, MD PhD, Debra M. Bensen-Kennedy, MD, Katie St. Ledger, MS, Alex Veldman, MD, Ingrid Pabinger, MD
Journal: Blood
Blood (2015) 126 (23): 3525.
https://doi.org/10.1182/blood.V126.23.3525.3525
Published: 2015
Journal Articles

Similar Levels of Complement Activation in Both Patients with Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome: The Report from the Korean TTP Registry

Doyeun Oh, MD, Ji Young Huh, MD PhD, So Young Chong, MD PhD, In-Ho Kim, MD, Soo-Mee Bang, MD PhD, Chul-Won Jung, Jong-Wook Lee, MD, Hong Ghi Lee, MD PhD, Sun Min Lee, MD, Yeo-Kyeoung Kim, MD PhD, Yong Park, MD PhD, Seongsoo Jang, MD PhD, Jin-Seok Kim, MD, Deog-Yeon Jo, MD PhD, Dae Young Zang, MD, Hwi-Joong Yoon, MD PhD, Ho-Young Yhim, MD PhD, Sang Kyun Sohn, MD PhD, Junshik Hong, MD, Won-Sik Lee, Ross I Baker
Journal: Blood
Blood (2014) 124 (21): 4195.
https://doi.org/10.1182/blood.V124.21.4195.4195
Published: 2014
Journal Articles

Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcγRIIa

Elizabeth E. Gardiner, Denuja Karunakaran, Jane F. Arthur, Fi-Tjen Mu, Maree S. Powell, Ross I. Baker, P. Mark Hogarth, Mark L. Kahn, Robert K. Andrews, Michael C. Berndt
Journal: Blood
Blood (2008) 111 (1): 165–174.
https://doi.org/10.1182/blood-2007-04-086983
Published: 2008
Journal Articles

Platelet glycoprotein Ibα Kozak polymorphism is associated with an increased risk of ischemic stroke

Clinical Trials & Observations
Ross I. Baker, John Eikelboom, Elizabeth Lofthouse, Nicole Staples, Vahid Afshar-Kharghan, José A. López, Yang Shen, Michael C. Berndt, Graeme Hankey
Journal: Blood
Blood (2001) 98 (1): 36–40.
https://doi.org/10.1182/blood.V98.1.36
Published: 2001